Jovanović A, Jovanović S, Lorenz E, Terzic A
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn, USA.
Circulation. 1998 Oct 13;98(15):1548-55. doi: 10.1161/01.cir.98.15.1548.
Opening of cardiac ATP-sensitive K+ (KATP) channels has emerged as a promising but still controversial cardioprotective mechanism. Defining KATP channel function at the level of recombinant channel proteins is a necessary step toward further evaluation of the cardioprotective significance of this ion conductance.
KATP channel deficient COS-7 cells were found to be vulnerable to chemical hypoxia-reoxygenation injury that induced significant cytosolic Ca2+ loading (from 97+/-3 to 236+/-11 nmol/L). In these cells, the potassium channel opener pinacidil (10 micromol/L) did not prevent Ca2+ loading (from 96+/-3 nmol/L before to 233+/-12 nmol/L after reoxygenation) or evoked membrane current. Cotransfection with Kir6.2/SUR2A genes, which encode cardiac KATP channel subunits, resulted in a cellular phenotype that, in the presence of pinacidil (10 micromol/L), expressed K+ current and gained resistance to hypoxia-reoxygenation (Ca2+ concentration from 99+/-7 to 127+/-11 nmol/L; P>0.05). Both properties were abolished by the KATP channel blocker glyburide (1 micromol/L). In COS-7 cells transfected with individual channel subunits Kir6.2 or SUR2A, which alone do not form functional cardiac KATP channels, pinacidil did not protect against hypoxia-reoxygenation.
The fact that transfer of cardiac KATP channel subunits protected natively KATP channel deficient cells provides direct evidence that the cardiac KATP channel protein complex harbors intrinsic cytoprotective properties. These findings validate the concept that targeting cardiac KATP channels should be considered a valuable approach to protect the myocardium against injury.
心脏ATP敏感性钾(KATP)通道的开放已成为一种有前景但仍存在争议的心脏保护机制。在重组通道蛋白水平上定义KATP通道功能是进一步评估这种离子电导的心脏保护意义的必要步骤。
发现缺乏KATP通道的COS-7细胞易受化学性缺氧-复氧损伤,这种损伤会导致显著的胞质Ca2+负荷增加(从97±3增加到236±11 nmol/L)。在这些细胞中,钾通道开放剂吡那地尔(10 μmol/L)不能防止Ca2+负荷增加(复氧前为96±3 nmol/L,复氧后为233±12 nmol/L)或诱发膜电流。与编码心脏KATP通道亚基的Kir6.2/SUR2A基因共转染,产生了一种细胞表型,在存在吡那地尔(10 μmol/L)的情况下,该表型表达K+电流并获得了对缺氧-复氧的抗性(Ca2+浓度从99±7增加到127±11 nmol/L;P>0.05)。这两种特性都被KATP通道阻滞剂格列本脲(1 μmol/L)消除。在单独转染不形成功能性心脏KATP通道的单个通道亚基Kir6.2或SUR2A的COS-7细胞中,吡那地尔不能保护细胞免受缺氧-复氧损伤。
心脏KATP通道亚基的转移保护了天然缺乏KATP通道的细胞,这一事实提供了直接证据,表明心脏KATP通道蛋白复合物具有内在的细胞保护特性。这些发现证实了这样一个概念,即靶向心脏KATP通道应被视为保护心肌免受损伤的一种有价值的方法。